Xencor, Inc(NASDAQ:XNCR) 
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. The company's product candidates include Obex...
Website: http://www.xencor.com
Founded: 1997
Full Time Employees: 166
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.69
H 8.87
L 8.45
C 8.69
V 1,098,728
10EMA 8.69
20EMA 8.69
60EMA 8.69
120EMA 8.69
250EMA 8.69